Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations

被引：11
作者：
Al-Mahayri, Zeina N. [1 ]
Patrinos, George P. [1 ,2 ]
Ali, Bassam R. [1 ]
机构：
[1] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates
[2] Univ Patras, Dept Pharm, Sch Hlth Sci, Univ Campus, Patras, Greece
来源：
PHARMACOGENOMICS | 2017年 / 18卷 / 07期
关键词：
acute lymphocytic leukemia; adverse side effects; ALL; anthracyclines; asparaginase; chemotherapy; glucocorticoids; methotrexate; pharmacogenomics; thiopurines; vincristine; PROMOTER VARIABLE NUMBER; TPMT GENE-TRANSCRIPTION; THIOPURINE METHYLTRANSFERASE; INDUCED CARDIOTOXICITY; PERSONALIZED MEDICINE; CHILDHOOD-CANCER; DEPENDENT MANNER; DRUG TOXICITY; ITPA GENE; POLYMORPHISMS;
D O I：
10.2217/pgs-2017-0005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Despite the significant advances achieved in pediatric acute lymphocytic leukemia (ALL) treatment, adverse side effects of drugs remain a challenging issue. Numerous ALL pharmacogenomic studies have been conducted to elucidate the predisposing genetic factors for their development. Plausible pharmacogenomic data are available for the osteonecrosis associated with glucocorticoids, the neurotoxicity associated with vincristine and the cardiotoxicity related to anthracyclines. However, these data have not been fully translated into the clinic due to several limitations, most importantly the lack of reliable evidence. The most robust pharmacogenomics data are those for thiopurines and methotrexate use, with evidence-based preemptive testing recommendations for the former. Pharmacogenomics has a significant potential utility in pediatric ALL treatment regimens. In this review, gaps and limitations in this field are emphasized, which may provide a useful guide for future research design.
引用
收藏
页码：687 / 699
页数：13
相关论文
共 72 条
[1]   Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity [J].
Alves, S ;
Amorim, A ;
Ferreira, F ;
Prata, MJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :165-174
[2]  
[Anonymous], CHILDH ACT LYMPH LEU
[3]   NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease [J].
Asada, Ayumi ;
Nishida, Atsushi ;
Shioya, Makoto ;
Imaeda, Hirotsugu ;
Inatomi, Osamu ;
Bamba, Shigeki ;
Kito, Katsuyuki ;
Sugimoto, Mitsushige ;
Andoh, Akira .
JOURNAL OF GASTROENTEROLOGY, 2016, 51 (01) :22-29
[4]   Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects [J].
Azimi, Fatemeh ;
Mortazavi, Yousef ;
Alavi, Samin ;
Khalili, Mitra ;
Ramazani, Ali .
LEUKEMIA RESEARCH, 2015, 39 (10) :1048-1054
[5]   The Pharmacogenomics of Vincristine-Induced Neuropathy On Pins and Needles [J].
Berg, Stacey L. ;
Parsons, D. Williams .
JAMA ONCOLOGY, 2015, 1 (07) :975-976
[6]   Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:Quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer [J].
Blanco, Javier G. ;
Leisenring, Wendy M. ;
Gonzalez-Covarrubias, Vanessa M. ;
Kawashima, Toana I. ;
Davies, Stella M. ;
Relling, Mary V. ;
Robison, Leslie L. ;
Sklar, Charles A. ;
Stovall, Marilyn ;
Bhatia, Smita .
CANCER, 2008, 112 (12) :2789-2795
[7]   Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines [J].
Chien, Wei-Wen ;
Le Beux, Celine ;
Rachinel, Nicolas ;
Julien, Michel ;
Lacroix, Claire-Emmanuelle ;
Allas, Soraya ;
Sahakian, Pierre ;
Cornut-Thibaut, Aurelie ;
Lionnard, Loic ;
Kucharczak, Jerome ;
Aouacheria, Abdel ;
Abribat, Thierry ;
Salles, Gilles .
SCIENTIFIC REPORTS, 2015, 5
[8]   Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers [J].
Chua, E. W. ;
Cree, S. ;
Barclay, M. L. ;
Doudney, K. ;
Lehnert, K. ;
Aitchison, A. ;
Kennedy, M. A. .
PHARMACOGENOMICS JOURNAL, 2015, 15 (05) :414-421
[9]   Treatment of Pediatric Acute Lymphoblastic Leukemia [J].
Cooper, Stacy L. ;
Brown, Patrick A. .
PEDIATRIC CLINICS OF NORTH AMERICA, 2015, 62 (01) :61-+
[10]  
Coulthard S. A., 2001, Pharmacogenomics Journal, V1, P254
12345678